Publication: Overcoming chemoresistance in triple negative breast cancer by bromodomain inhibition
dc.contributor.coauthor | Philpott, M. | |
dc.contributor.coauthor | Cribbs, A. | |
dc.contributor.coauthor | Oppermann, U. | |
dc.contributor.coauthor | Onder, T. T. | |
dc.contributor.department | Department of Molecular Biology and Genetics | |
dc.contributor.department | Graduate School of Health Sciences | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Aksu, Ali Cenk | |
dc.contributor.kuauthor | Ayhan, Ceyda Açılan | |
dc.contributor.kuauthor | Bayram, Özlem Yedier | |
dc.contributor.kuauthor | Cevatemre, Buse | |
dc.contributor.kuauthor | Cingöz, Ahmet | |
dc.contributor.kuauthor | Değirmenci, Nareg Pınarbaşı | |
dc.contributor.kuauthor | Esin, Beril | |
dc.contributor.kuauthor | Kayabölen, Alişan | |
dc.contributor.kuauthor | Önder, Tuğba Bağcı | |
dc.contributor.schoolcollegeinstitute | College of Engineering | |
dc.contributor.schoolcollegeinstitute | College of Sciences | |
dc.contributor.schoolcollegeinstitute | GRADUATE SCHOOL OF HEALTH SCIENCES | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2024-11-09T23:39:18Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: Triple negative breast cancer (TNBC) is an aggressive subtypeofbreastcancerwithpoorprognosis.TNBCcellsdonotexpress receptorsforestrogen,progesteroneorHer2,eliminatingthepossibilityof targetedtherapyapplications.Therefore,current treatmentoptionforTNBC is limitedwithsurgery followedbyconventional chemotherapy.However, acquiredresistancetochemotherapyisamajorchallengethatisassociated withrelapse,whichisdrivenbycoordinatedactionsofgeneticandepigenetic events. MaterialsandMethods:Weaimedtoelucidatetherolesoffullspectrum ofepigeneticmodifiersinmaintenanceandreversionofchemoresistancein TNBC.TogenerateinvitromodelsofchemoresistantTNBC,weexposed3 different TNBC cell lines to escalating doses of taxane (paclitaxel). Transcriptome analysis by RNA-sequencingwere performed to reveal changesthat regulatechemoresistance.Withourcustomepigenome-wide CRISPR-Cas9library(EpigeneticKnock-OutLibrary-EPIKOL)targetingall chromatinreaders,writers,erasersandassociatedproteins,wesystematicallyinterrogatedtherolesofepigeneticmodifiersinchemoresistantTNBC cells.Wealsoconductedmediumscalechemicalscreensutilizingepigenetic probelibrariesinchemoresistantcells. Results:RNAsequencingonpairedsensitiveandchemoresistancecell linesrevealedABCB1upregulationasamajordriverofresistance.Inhibition of themembersofMLLandSWI/SNFcomplexes, aswell as thegenes relatedwithhistoneubiquitinationandacetyl-mark readers re-sensitized chemoresistantcellstopaclitaxel.Amemberof thebromodomainprotein family,BRPF1,cameasacommonhit inourchemical screenaswellas geneticscreens.KnockoutofBRPF1or itschemical inhibitioncompletely abolishedpaclitaxel resistanceandmodulatedABCB1expression. Conclusions:ThroughEPIKOLscreensonchemoresistantTNBCcells coupledwithchemicalscreens,weidentifiednovelepigeneticmodifiersthat arecrucial formaintainingandovercomingdrug resistance.Collectively, thesefindingsprovideabasistodevelopcombinationtherapiestoefficiently killchemoresistantTNBC. | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.openaccess | NO | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | Scientific and Technological Research Council of Turkey (TUBITAK) [1003- 216S461] This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) 1003- 216S461 Grant | |
dc.description.volume | 174 | |
dc.identifier.eissn | 1879-0852 | |
dc.identifier.issn | 0959-8049 | |
dc.identifier.scopus | 2-s2.0-85143781807 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/13076 | |
dc.identifier.wos | 876973400176 | |
dc.keywords | Epigenetics | |
dc.keywords | Breast cancer | |
dc.keywords | Drug resistance | |
dc.language.iso | eng | |
dc.publisher | Elsevier Sci Ltd | |
dc.relation.ispartof | European Journal of Cancer | |
dc.subject | Oncology | |
dc.title | Overcoming chemoresistance in triple negative breast cancer by bromodomain inhibition | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Bayram, Özlem Yedier | |
local.contributor.kuauthor | Cingöz, Ahmet | |
local.contributor.kuauthor | Aksu, Ali Cenk | |
local.contributor.kuauthor | Değirmenci, Nareg Pınarbaşı | |
local.contributor.kuauthor | Esin, Beril | |
local.contributor.kuauthor | Kayabölen, Alişan | |
local.contributor.kuauthor | Cevatemre, Buse | |
local.contributor.kuauthor | Ayhan, Ceyda Açılan | |
local.contributor.kuauthor | Önder, Tuğba Bağcı | |
local.publication.orgunit1 | College of Engineering | |
local.publication.orgunit1 | GRADUATE SCHOOL OF HEALTH SCIENCES | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit1 | College of Sciences | |
local.publication.orgunit2 | Department of Molecular Biology and Genetics | |
local.publication.orgunit2 | School of Medicine | |
local.publication.orgunit2 | Graduate School of Health Sciences | |
relation.isOrgUnitOfPublication | aee2d329-aabe-4b58-ba67-09dbf8575547 | |
relation.isOrgUnitOfPublication | 2f870f28-12c9-4b28-9465-b91a69c1d48c | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | aee2d329-aabe-4b58-ba67-09dbf8575547 | |
relation.isParentOrgUnitOfPublication | 8e756b23-2d4a-4ce8-b1b3-62c794a8c164 | |
relation.isParentOrgUnitOfPublication | af0395b0-7219-4165-a909-7016fa30932d | |
relation.isParentOrgUnitOfPublication | 4c75e0a5-ca7f-4443-bd78-1b473d4f6743 | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 8e756b23-2d4a-4ce8-b1b3-62c794a8c164 |